A Thousandfold Boost in Glass Knowledge Helps Pharma Industry to Better Package Drugs
News Mar 25, 2015
SCHOTT has reached the landmark of training more than 3,000 professionals at its FIOLAX Academy. Started in 2010, FIOLAX Academy events share the latest information on the composition, properties and production of high quality pharma glass. This knowledge helps the industry to manufacture and use even better vials, syringes, ampoules, and cartridges for the optimal storage of medicines – supporting pharma companies in their efforts to minimize risks and ensure patient safety.
Participants have come from within specialist companies that are converting glass tubes to primary glass packaging, and from pharmaceutical businesses. The academy takes its name from SCHOTT FIOLAX® glass tubing, which has grown to become the gold standard ‘raw material’ for glass containers in the pharma industry. SCHOTT hosts FIOLAX Academy events in many of the world’s leading and emerging pharmaceutical markets.
Since 2010 there have been more than 150 FIOLAX Academies in countries throughout the world, from Europe and US to South and Central America, India, Japan, and China. Dr. Bettine Boltres, Product Manager Pharmaceutical Tubing and responsible for this training program, explains, “At SCHOTT we are thrilled to have already trained so many people in the FIOLAX Academy. We are continually expanding the programme to offer a complete training experience, covering topics such as drug-container interactions, regulatory requirements and glass quality. Through these training events we help our partners to improve quality and to increase efficiency and in turn advance their position in both their domestic and international markets.”
The FIOLAX Academy modular training programme has been designed in six parts. SCHOTT experts share the latest industry information on the use of glass in pharmaceutical ampoule, vial, cartridge and syringe manufacturing. Specialist insight is also provided for drug makers and contract fillers about the handling of glass during the filling processes to help decrease the risk of breakages.
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Allergy Amplifier Implicated in Asthma Also Intensifies Food AllergyNews
Scientist who previously reported that a small protein, aptly named histamine-releasing factor, played a pro-inflammatory role in asthma have now shown that it also serves as a “food allergy amplifier”. This work paves the way for blood tests to predict which patients will respond to allergy therapy, and strongly supports the idea that drugs designed to block HRF could prevent food allergy attacks.READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE